Our blog

Generative AI is transforming every facet of our economy. The timing couldn’t be better for the healthcare space which is in dire need of innovation, efficiency and affordability solutions.

In aid of our Simone Taylor Fund, a few members of our team took on the Leeds full and half marathon in May, raising funds for a variety of cancer charities, and managed to raise an incredible total of £1,167!

Tanya Riding took to the LSI Emerging MedTech Summit conference in California and noticed an abundance of individuals looking to springboard their startup company into success. Transitioning from the conceptual stage to building a successful startup is a formidable journey for founder CEOs.

As the leader of a business, you hold the reins of your organization’s destiny, and the quest for top talent is paramount. While internal talent acquisition teams can get you so far, consider the broader, strategic advantage that utilizing an external search partner for the most critical hires can provide.

In the dynamic, fast-paced world of Medtech, talent scarcity remains a persistent challenge. Leaders must grapple with identifying, attracting and retaining the very best in a highly competitive market. Those that have knowledge, have relationships but above all - have raw talent. 

Recruiting executive leadership within the MedTech industry, Tanya Ridding has seen a slight improvement in female diversity across the industry over the years, but there are still many challenges faced.

The EUS can be used to diagnose and treat a variety of conditions, including pancreatic cancer, gall bladder cancer, oesophageal cancer, Barrett’s oesophagus, gastric cancer, diseases of the liver, spleen, kidneys, IBD and much more.

The capsule endoscopy market is not only expanding but is poised to reach a staggering global value of over $1.09 trillion by 2030. What is driving this unprecedented growth? Tanya Ridding explores the capsule endoscopy market's transformative rise.

Colorectal Cancer stands as the third leading cause of cancer-related deaths in the US. Early detection through colonoscopies is crucial for preventing the progression of CRC. However, high missed detection rates pose a challenge, putting patients at risk even with regular screenings.